← Back to Search

Behavioral Intervention

GOLD Program for Childhood Cancer Family Support

N/A

Recruiting

Led By Victoria E. Cosgrove, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 month

Awards & highlights

Study Summary

This trial will study a psychological intervention delivered online to parents of children with cancer. The intervention will be evaluated to see if it is effective.

Who is the study for?

This trial is for primary caregivers of children under 18 recently diagnosed with blood or brain/CNS cancer. Caregivers must be proficient in English and able to consent to research. Children/siblings over age 8 can also participate. Those with active suicidal thoughts or not caring for a child diagnosed within the last six months are excluded.Check my eligibility

What is being tested?

The GOLD Program, a virtual psychotherapeutic and educational intervention, is being tested against the usual treatment methods (TAU) for reducing anxiety and promoting resilience among families of youth with cancer.See study design

What are the potential side effects?

Since this is a psychological support program rather than a medical treatment, traditional side effects like those seen with medications are not expected. However, participants may experience emotional discomfort during discussions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of caregivers who enroll in the GOLD program

Secondary outcome measures

Acceptability of the GOLD Program for caregivers

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: GOLD Psychosocial ProgramExperimental Treatment1 Intervention

Participant will receive a 2-hour interventional session. Its content will consist of two modules: (1) psychoeducation and coping, providing information in content areas such as side effects of cancer treatments, fever protocols, role disruption and (2) stress, triggers, and self care, where caregivers will be briefed on symptoms of and reactions to traumatic stress in order to help parents accurately label thoughts and emotions related to their child's cancer diagnosis.

Group II: Treatment-as-Usual (TAU)Active Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,386 Previous Clinical Trials

17,333,968 Total Patients Enrolled

Victoria E. Cosgrove, PhDPrincipal InvestigatorStanford University

Media Library

GOLD Program (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05415007 — N/A

Cancer Research Study Groups: GOLD Psychosocial Program, Treatment-as-Usual (TAU)

Cancer Clinical Trial 2023: GOLD Program Highlights & Side Effects. Trial Name: NCT05415007 — N/A

GOLD Program (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05415007 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many patients are enrolled in this experiment?

"Affirmative. Clinicaltrials.gov data indicates that recruitment for this medical trial, which launched on March 23rd 2022, is ongoing. 40 patients must be recruited from one research facility."

Answered by AI

Is the age limit for this research project restricted to individuals under 25?

"This trial seeks participants aged 8 to 18 years old."

Answered by AI

Are any eligible participants able to join this experiment currently?

"Assertively, clinicaltrials.gov provides evidence that this research endeavour is open to new participants. It was originally published on March 23rd 2022 and recently amended on June 8th 2022; 40 individuals between a single site are needed for completion of the study."

Answered by AI

What type of person is the ideal participant for this clinical experiment?

"To qualify for inclusion in this study, participants must be between the age of 8 and 18 years old with a diagnosis of leukemia or lymphocytic cancer. Forty total individuals are required for completion of the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

2022. "GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05415007.